Rite Aid Corporation, a prominent American drugstore chain, is contemplating shuttering 400 to 500 outlets amidst bankruptcy deliberations. While talks are ongoing, the company's massive $3.3 billion debt looms large. Concurrently, federal lawsuits and a DOJ action over alleged mishandling of opioid prescriptions challenge the pharmacy's operations.
Currently, Rite Aid is negotiating the terms of a bankruptcy plan, which may result in the permanent closure of its stores, now numbering more than 2,100 in the 17 U.S. states. It was reported that some individuals familiar with the ongoing talks with creditors told the Wall Street Journal that the company suggested closing up to 500 pharmacies in bankruptcy.
It was also said that Rite Aid also proposed to either sell or allow creditors to take over the remaining drug stores. As per Fox Business, there is one group of bondholders that prefers to liquidate a greater number of stores, and officials are said to be discussing the exact number.
But while there is an ongoing talk, Rite Aid said they have not yet made any decision. It was already reported that the drugstore chain is planning to file for bankruptcy protection due to the more than $3.3 billion debt it has incurred. It also faces thousands of federal lawsuits about its alleged part in the sweeping spread of opioids.
Washington Examiner reported that Rite Aid is also being confronted by huge pressure from the U.S. Department of Justice, which filed a lawsuit against the company for allegedly "knowingly" filling up unlawful prescriptions for controlled substances. The DOJ said the pharmacy giant missed "obvious red flags" that the medications it sold were being abused by customers such as medical fentanyl and oxycodone.
Rite Aid disagreed with how the government described its handling of opioid medications. It also denied the claims it is filling illegal prescriptions.
Photo by: Chance Pereira/Flickr(CC BY-SA 2.0)


Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Fed Chair Kevin Warsh Launches Task Forces to Overhaul U.S. Monetary Policy Framework
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Gold Prices Slip as Stronger Dollar, Fed Rate Outlook Weigh on Bullion
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
US Stock Futures Steady as US-Iran Tensions and Fed Inflation Concerns Weigh on Markets
Deutsche Bank Sees Global Capital Shifts Reshaping Long-Term U.S. Dollar Outlook
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Oil Prices Slip but Stay on Track for Weekly Gains as U.S.-Iran Conflict Persists
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Gold Prices Set for Weekly Loss as Iran Tensions and Fed Rate Outlook Weigh
Trump, Canada Reach Gordie Howe Bridge Deal Ahead of July 27 Opening 



